Invasive group A streptococcal infection in injecting drug users and non-drug users in a single UK city

Journal of Infection

Volumn 54, Issue 5, 2007, Pages 422-426

  Curtis, S J ^a,b   Tanna, A ^c   Russell, H H ^a   Efstratiou, A ^c   Paul, J ^b   Cubbon, M ^b   Sriskandan, S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Department of Microbiology and Infection ^*  (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

emm type; Genotype; Injecting drug user; Streptococcus pyogenes; Superantigen

Indexed keywords

BACTERIAL TOXIN; SUPERANTIGEN;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ABUSE; GENOTYPE; HUMAN; INJECTION SITE ABSCESS; MORTALITY; NONHUMAN; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; BLOOD; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; GENOTYPE; GREAT BRITAIN; HOSPITALS, URBAN; HUMANS; INFANT; MIDDLE AGED; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUBSTANCE ABUSE, INTRAVENOUS; SUPERANTIGENS;

EID: 34147092621     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.10.004     Document Type: Article

References (12)

1. Cone L., Woodard D.R., Schlievert P.M., and Tomory G.S. Clinical and bacteriologic observations of a toxic-shock like syndrome due to Streptococcus pyogenes. N Engl J Med 317 (1987) 146-149
2. Lechot P., Schaad H.J., Graf S., Tauber M., and Muhlemann K. Group A Streptococcus clones causing repeated epidemics and endemic disease in intravenous drug users. Scand J Infect Dis 33 (2001) 41-46
3. Efstratiou A., Emery M., Lamagni T.L., Tanna A.I., Warner M., and George R.C. Increasing incidence of group A streptococcal infections amongst injecting drug users in England and Wales. J Med Microbiol 52 (2003) 525-526
4. Unnikrishnan M., Altmann D., Proft T., Wahid J., Cohen J., Fraser J.D., et al. The streptococcal superantigen SMEZ is the major immunoactive agent of Streptococcus pyogenes. J Immunol 169 (2002) 2561-2569
5. Kawabata S., Tamura Y., Murakami J., Terao Y., Nakagawa I., and Hamada S. A novel, anchorless streptococcal surface protein that binds to human immunoglobulins. Biochem Biophys Res Commun 296 (2002) 1329-1333
6. Facklam R., Beall B., Efstratiou A., Fischetti V., Johnson D., Kaplan E., et al. Emm typing and validation of provision M types for group A streptococci. Emerging Infect Dis 5 (1999) 247-253
7. Ekelund K., Skinhoj P., Madsen J., and Konradsen H.B. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol 43 (2005) 1789-1796
8. Sierra J.M., Sanchez F., Castro P., Salvado M., de la Red G., Libois A., et al. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003. Medicine (Baltimore) 85 (2006) 139-146
9. Schmitz F.J., Beyer A., Charpentier E., Normark B.H., Schade M., Fluit A.C., et al. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188 (2003) 1578-1586
10. Kalia A., and Bessen D.E. Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol 186 (2004) 110-121
11. Vlaminckx B.J., Mascini E.M., Schellekens J., Schouls L.M., Paauw A., Fluit C., et al. Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41 (2003) 4941-4949
12. Bohlen L.M., Muhlemann K., Dubuis O., Aebi C., and Tauber M.G. Outbreak among drug users caused by a clonal strain of group A streptococcus. Emerging Infect Dis 6 (2000) 175-179